英文摘要
|
Aortic stenosis is not a disease classification in TCM, but according to the clinical symptoms of aortic stenosis, it shares the same attributes as the TCM disease classified as "heart impediment "(心痹), "chest impediment "(胸痹) or "palpitations"(心悸). Based on TCM theory, the cause of disease is related to congenital deficiency, invasion of exogenous pathogens and feeble body due to old age. These factors led to the weakness of qi, blood, yin and yang, which in turn caused phlegm blockage and blood stasis, resulted in the lack of nutrients for heart support, loss of flowing rhythm of the heart and pulse, and thus, the emergence of the clinical symptoms. A 64-year-old woman, presented with the intermittent chest tightness, chest pain and breathing difficulties was admitted into the hospital in 2009. The patient was diagnosed with severe aortic valve stenosis and surgery was recommended by the cardiologist. However, patient refused surgery treatment and she seek for Traditional Chinese medicine (TCM) outpatient clinic.The TCM treatment plan for this case was to nourish the qi and blood which promoted the blood circulation to achieve the balance of yin and yang. The main TCM formula during the course were "Mu-Fang-Ji-Tang", "Zhi-Gan-Cao-Tang" and "Sheng-Mo-Yin", while the TCM single herbs were "Dan-Shan", "San-Qi", "Yu-Jin", and "Xiang-Fu". Since the patient has received six years of TCM treatment, the clinical symptoms of chest tightness and breathing difficulties has improved well and her condition is currently stabilized. At present, the patient is still undergoing outpatient TCM treatment. This case report could be presented as an effective clinical case study of aortic stenosis using TCM treatment.
|
参考文献
|
-
張清貿、施柏瑄、楊仕哲(2017)。心腦主神明學說的沿革。中醫藥雜誌,28,1。
連結:
-
Bonow, RO(2006).ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.Circulatio,114,84.
-
Chen, Y. H.,Hsu, T. L.,Wu, M. H.,Yu, W. C.,Wu, H. M.,Lin, S. M.,Chang, H. H.(2011).The acute and 3-month outcomes of transcatheter aortic valve implantation in Taiwan.Acta Cardiologica Sinica,27,213-220.
-
Hawkey,Lauck,Perpetua,Fowler,Schnell,Speight,Leon(2014).Transcatheter aortic valve replacement program development :Recommendations for best practice.Catheterization and Cardiovascular Interventions,84,859-867.
-
Li, Yi-Heng,Ueng, Kwo-Chang,Charng, Jiann-Shing,Charng, Min-Ji,Lin, Tsung-Hsien,Chien, Kuo-Liong,Wang, Chih-Yuan,Chao, Ting-Hsing,Liu, Ping-Yen,Su, Cheng-Huang,Chien, Shih-Chieh,Liou, Chia-Wei,Tang, Sung-Chun,Lee, Chun-Chuan,Yu, Tse-Ya,Chen, Jaw-Wen,Wu, Chau-Chung,Yeh, Hung-I(2017).2017 Taiwan lipid guidelines for high risk patients.Journal of the Formosan Medical Association,116,217-248.
-
Otto, Catherine M.(2004).Aortic stenosis and hyperlipidemia: Establishing a cause-effect relationship.American Heart Journal,147,761-763.
-
Otto, CM,Kuusisto, J,Reichenbach, DD(1994).Characterization of the early lesion of degenerative valvular aortic stenosis: histological and immunohistochemical studies.Circulation,90,844-853.
-
Peltier, Marcel,Trojette, Faouzi,Sarano, Maurice Enriquez,Grigioni, Michel A.,Slama, Michel A.,Tribouilloy, Christophe M.(2003).Relation Between Cardiovascular Risk Factors and Nonrheumatic Severe Calcific Aortic Stenosis Among Patients With a Three-Cuspid Aortic Valve.The American Journal of Cardiology,91,97-99.
-
Roberts, WC(1986).The senile cardiac calcification syndrome.Am J Cardiol.,58,572-574.
-
Shu, C,Chen, S,Qin, T(2016).Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China.Scientific Reports,6,27253.
-
Stewart, BF,Siscovick, D,Lind, BK(1997).Clinical factors associated with calcific aortic valve disease.Cardiovascular Health Study.J Am Coll Cardiol,29,630-634.
-
Stewart,Siscovick,Lind(1997).Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.J Am Coll Cardiol.,29,630-634.
-
Sverdlov, Aaron L,Ngo, Doan TM,Chapman, Matthew J,Ali, Onn Akbar,Chirkov, Yuliy Y,Horowitz, John(2011).Pathogenesis of aortic stenosis: not just a matter of wear and tear.Am J Cardiovasc Dis,1,185-199.
-
木下修(2005)。木防己湯對難治性心功能不全的效果。國外醫學中醫中藥分冊,27,225-226。
-
王宗偉(1998)。木防己湯對鼠心肌損傷模型的保護作用。國外醫藥─植物藥分冊,13,274。
-
王綿之、肖俊平、劉淑清(1991)。方劑學。貴州科技出版社。
-
王樹岩(2009)。主動脈瓣疾病與心力衰竭。中國醫刊,44,63-65。
-
冉先德(1993)。中華藥海。哈爾濱:哈爾濱出版社。
-
矢數道明(2008)。臨床應用漢方處方解說。北京:學苑出版社。
-
安炎(2009)。香附在冠心病治療中的應用。山西中醫,24,6。
-
吳葆傑(1983)。中草藥藥理學。北京:人民衛生出版社。
-
李仁述(1988)。生脈飲出處小考。成都中醫學院學報,11,45-46。
-
李方潔(1989)。路志正教授辨治心痹四法。遼寧中醫雜誌,4
-
沈烈行、馮曉、高秀芝(2003)。生脈飲藥理作用與臨床應用。醫藥報導,22,634-635。
-
岳冬輝、蘇穎(2010)。淺談心痹的辨證論治體會。陜西中醫,31,7。
-
胡久略、黃顯章(2008)。炙甘草湯抗心律失常作用的實驗研究。時珍國醫國藥,19,1189-1190。
-
馬光亞(1997)。臨床辨證與經驗實錄。台北:知音出版社。
-
高占毅、劉寶恒(2012)。炙甘草湯應用拾零。光明中醫,27,1029。
-
高潤林、孫林梅(2005)。益氣活血法治療缺血性中風的探討。中國熱帶醫學,5,7。
-
國家藥典委員會(2015)。中華人民共和國藥典。中國醫藥科技出版社。
-
張乃蔚(2014)。辨證論治心痹50 例。中醫臨床研究,6,21。
-
張軍(2007)。生脈飲加味治療室性期前收縮42 例。河北中醫,29,138。
-
張麗娜、鄭雅芳、楊旭(2006)。中西醫理論結合探討心痹心痛的證治方藥。中醫藥學報,34,1。
-
梁文儀、陳文靜、楊光輝(2016)。丹參酚酸類成分研究進展。中國中藥雜誌,41,806-812。
-
許琳、唐海林、龔一萍(2015)。加減木防己湯對缺血性心力衰竭大鼠心肌肌漿網Ca2+-ATP 酶及心肌重構的影響。中華中醫藥學刊,33,2220-2224。
-
許琳、陳燁文、龔一萍(2014)。論木防己湯方證特點和發展。北京中醫藥大學學報,37,729。
-
郭晶晶(2015)。炙甘草湯臨床應用進展研究。遼寧中醫藥大學學報,17,106-109。
-
陳宇飛、王四旺、羅卓荊(2011)。丹參配伍三七和川芎不同提取工藝對丹參酮IIA含量的影響。現代生物醫學進展,11,127-130。
-
陳林、張麗、戴雲、王世祥、趙新鋒、鄭曉暉(2007)。使藥郁金對君藥丹參藥代動力學的影響研究。中國民族醫藥雜誌,7,55-57。
-
陳芬燕、郭韌、張華奎(2015)。丹參酮IIA 的心血管藥理作用研究進展。中國中藥雜誌,40,1649-1653。
-
陳朝金(2012)。生脈飲治療難治性心力衰竭30 例臨床觀察。中醫臨床研究,4,95-96。
-
陳會君、胡妮娜(2012)。炙甘草湯對慢性病毒性心肌炎小鼠心肌病理損傷的影響。求醫問藥,10,54-55。
-
森立之輯(2016)。神農本草經。北京:科學技術出版社。
-
焦樹德(2004)。心痹的辨證論治。河北中醫,26,85-87。
-
焦樹德(2007)。心痹的辨證論治。繼續醫學教育,21,19。
-
黃青、何曉燕(2011)。淺談心痹的辨證論治。四川中醫,29,30-32。
-
黃傳兵(2010)。周宜軒教授心痹辨治經驗。黑龍江中醫藥
-
楊維益(1990)。中醫診斷學。貴州:貴州人民出版社。
-
雍履平(1990)。葉天士通法治痛探析。中醫雜誌,1
-
趙彥萍(2006)。木防己湯加減對慢性充血性心衰患者心功能影響的臨床觀察。北京中醫藥大學學報(中醫臨床版),13,30-31。
-
齊南、濮正琪、王銳(2005)。《內經》心痹、胸痹與心痛之辨別。江西中醫學院學報,17,5。
-
劉文兵(2009)。瓜蔞薤白湯加減治療心痹之探討。光明中醫,24,1。
-
劉慶林(2002)。香附藥對的臨床應用舉隅。湖南中醫藥導報,8,11。
-
鄧愛平、郭蘭萍、詹志來(2016)。丹參本草考證。中國中藥雜誌,41,4274-4279。
-
錢元龍(1993)。淺論心痹的病機與證治。江西中醫藥,24,4。
-
龍海(2013)。主動脈瓣狹窄病的中醫治療體會。黑龍江中醫世界最新醫學信息文摘,13,36。
-
薛清、韓林(2011)。老年退化性鈣化性主動脈瓣狹窄的診療。國際心血管病雜誌,38,206。
-
韓淑嫻、游雲(2016)。三七總皂苷心腦血管藥理作用及其溶血反應。中國中藥雜誌,41,818-822。
-
羅徵祥(2010)。心臟瓣膜病治療的發展。嶺南心血管病雜誌,16,343-351。
-
龔婉、肖揚、王毅(2013)。丹參總酚酸及三七總皂苷配伍對缺氧復氧損傷心肌細胞的保護作用研究。中國中藥雜誌,38,1046-1051。
|